Skip to main content

Mizuho Capital — Portfolio, Page 11

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

472
Companies
$5.0B
Total invested
$13.3M
Avg. check
70
Industries
Information Technology 5Biotechnology 4Health Care 4Artificial Intelligence (AI) 4Medical 3Pharmaceutical 3+64 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 241264 of 472
FiT
August 2025

FiT is a digital platform that creates and develops a fitness app that allows users to join, cancel, and pause gym memberships.

Apps · Kawaramachi$10.2M Debt Financing
Luxna Biotech
August 2025

Luxana Biotech is a biotechnology firm aimed at developing nucleic acid drugs to enhance medical treatment for patients in need.

Biotechnology · Osaka$1.0M Series C
PlaceHolder
August 2025

PlaceHolder is Development and management of digital theme parks "Little Planet".

Architecture · TokyoSeries C
Terass
July 2025

Terass is a real estate agency that offers expert consultation and support services.

Commercial Real Estate · Tokyo$13.4M Series C
LegalOn Technologies
July 2025

LegalOn Technologies is an AI platform helping lawyers improve corporate legal operations efficiency with advanced legal AI tools.

Artificial Intelligence (AI) · Tokyo$50.0M Series E
A-SEEDS
July 2025

A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

Biotechnology · Matsumoto$15.0M Series A
Newmo
July 2025

Newmo develops ride-sharing service platform designed to provide a means of transport to local communities and consumers.

B2C · Tokyo$8.4M Series A
Morus
June 2025

Morus is a food technology firm that specializes in the research and development of sustainable protein and new food alternatives.

Alternative Protein · Tokyo$5.0M Series A
Miletos
June 2025

Miletos is the provider of AI expense scrutiny SaaS services.

Artificial Intelligence (AI) · Tokyo$6.8M Series A
Modalis Therapeutics
June 2025

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Biotechnology · TokyoPost Ipo Equity
Linea Innovations
June 2025

Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.

Energy · Roppongi$12.3M Series A
Ugo
June 2025

Ugo is a robotics solutions company that creates sustainable work environments by combining humans and robots.

Hardware · Higashi-shinagawaSeries Unknown
Startup Class
May 2025

Startup Class strives to discover and carefully select ambitious entrepreneurs , and provides with an opportunity.

Human Resources · Meguro$1.0M Series Unknown
Findy
May 2025

Findy is a human resource company that provides recruitment, employment, and staffing solutions with machine learning technology.

Career Planning · Tokyo$14.4M Series D
obniz
May 2025

obniz is an IT company that offers curated IoT systems to control sensors, actuators, and machines directly through the cloud.

Electronics · TokyoSecondary Market
Plainer
May 2025

Plainer is an IT company that provides software development, data management, and SaaS solutions.

Data Integration · Tokyo$2.8M Series A
SUPER STUDIO
May 2025

SUPER STUDIO is an IT services company that specializes in the development and provision of integrated commerce platforms.

Business Development · Tokyo$11.7M Series Unknown
ARCS
May 2025

ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.

Artificial Intelligence (AI) · Tokyo$1.8M Seed
Linqmed
May 2025

Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment.

Health Care · Chiba$2.0M Series B
Better Place
April 2025

Better Place is a financial technology company specializing in corporate pensions and retirement benefits.

Communities · Tokyo$2.6M Series D
KAICO
April 2025

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Alternative Medicine · Nishiku$3.8M Series B
Quemix
April 2025

Quemix is an information technology company that specializes in quantum computing solutions.

Cloud Computing · Tokyo$3.8M Series B
JIZAIE
April 2025

JIZAIE is an artificial intelligence firm that wants to combine VR, robots, and wearable computing to create a solution.

Artificial Intelligence (AI) · TokyoSeries A
GA Technologies Japan
March 2025

GA Technologies Japan offers real estate platform operation, rental property management, renovation planning, and design services.

Asset Management · Tokyo$1.3M Debt Financing

Where Mizuho Capital invests

Information Technology5
Biotechnology4
Health Care4
Artificial Intelligence (AI)4
Medical3
Pharmaceutical3

About Mizuho Capital's portfolio

How many companies has Mizuho Capital invested in?

Mizuho Capital has invested in 472 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mizuho Capital invest in?

Mizuho Capital's top investment sectors include Information Technology, Biotechnology, Health Care, Artificial Intelligence (AI), Medical. The firm invests across 70 different industry categories.

What is Mizuho Capital's largest investment?

Among tracked funding rounds, LegalOn Technologies received $50.0M in a Series E round. Mizuho Capital's total known invested capital is $5.0B.

What is the average investment size for Mizuho Capital?

Mizuho Capital's average investment size is $13.3M across its portfolio of 472 companies.

What are Mizuho Capital's most recent investments?

Recent Mizuho Capital portfolio additions include FiT, Luxna Biotech, PlaceHolder, Terass, LegalOn Technologies. These companies were founded in 2020 or later.

Reach the founders behind these 472 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →